Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CASIMERSEN for Muscular dystrophy: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 17 adverse event reports in the FDA FAERS database where CASIMERSEN was used for Muscular dystrophy.

Most Reported Side Effects for CASIMERSEN

Side Effect Reports % Deaths Hosp.
Product dose omission issue 253 33.0% 0 2
No adverse event 166 21.6% 0 0
Poor venous access 101 13.2% 0 5
Device issue 76 9.9% 0 1
Intentional dose omission 74 9.7% 0 0
Malaise 36 4.7% 0 1
Pyrexia 31 4.0% 1 4
Covid-19 29 3.8% 0 2
Influenza 18 2.4% 0 2
Pneumonia 17 2.2% 0 15
Product distribution issue 17 2.2% 0 0
Dehydration 15 2.0% 0 2
Cough 14 1.8% 0 0
Illness 14 1.8% 0 1
Exposure to sars-cov-2 12 1.6% 0 0

Other Indications for CASIMERSEN

Duchenne muscular dystrophy (406) Product used for unknown indication (342)

Other Drugs Used for Muscular dystrophy

DEFLAZACORT (1,542) ETEPLIRSEN (100) GOLODIRSEN (15) GIVINOSTAT (11) CELECOXIB (9) PREDNISONE (8) FENTANYL (7) PREGABALIN (7) RISDIPLAM (7) METHOTREXATE (6)

Related Pages

CASIMERSEN Full Profile All Muscular dystrophy Drugs CASIMERSEN Demographics CASIMERSEN Timeline